ddrg/super_eurlex huggingface dataset:
Prior notification of a concentration

(Case M.10574 - ADVENT / CALDIC)

Candidate case for simplified procedure

(Text with EEA relevance)

(2022/C 66/05)

1. On 31 January 2022, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Advent International Corporation and/or its affiliates (‘Advent’, USA), — Caldic Holdco B.V. (‘Caldic’, the Netherlands). Advent will acquire within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the whole of Caldic. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned: — Advent is a private equity investor based in Boston, USA, focusing on the acquisition of equity stakes and the management of investment funds in various sectors, including industrial, technology, retail, consumer and leisure, healthcare, and business and financial services, — Caldic is an international provider of value-add life sciences and specialty chemicals solutions serving customers in the life science and industrial sectors.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.10574 - ADVENT / CALDIC Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Prior notification of a concentration

(Case M.10514 – DASSAULT SYSTEMES INTERNATIONAL / SZSW / JV)

Candidate case for simplified procedure

(Text with EEA relevance)

(2022/C 72/09)

1. On 3 February 2022, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Dassault Systemes International SAS (‘DSI’, France), a wholly-owned subsidiary of Dassault Systèmes SE (France), which is in turn controlled by Groupe Industriel Marcel Dassault (France). — Beijing Shenzhou Aerospace Software Technology Co., Ltd (‘SZSW’, China), controlled by China Aerospace Science and Technology Corporation (China), which is in turn controlled by the State-owned Assets Supervision and Administration Commission of the State Council of the People’s Republic of China. — the Joint Venture (‘JV’, China). DSI and SZSW acquire within the meaning of Articles 3(1)b and 3(4) of the Merger Regulation joint control of the newly created JV. The concentration is accomplished by way of purchase of shares in a newly created company constituting the joint venture.

2. The business activities of the undertakings concerned are: — for DSI: development and marketing of product life-cycle management (‘PLM’) software, enabling 3D design, engineering, modelling, simulation, data management and process management. — for SZSW: development and marketing of software for various applications, including the air and space sector, only in China. — for the JV: supply of PLM software products and solutions in China, including the development of specific applications and the supply of associated services in the civil domain.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.10514 – DASSAULT SYSTEMES INTERNATIONAL / SZSW / JV Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Non-opposition to a notified concentration

(Case M.10547 – VOITH GROUP / VOITH HYDRO)

(Text with EEA relevance)

(2022/C 69/05)

On 27 January 2022, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in German language and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10547. EUR-Lex is the online point of access to European Union law.

(1) OJ L 24, 29.1.2004, p. 1.
Non-opposition to a notified concentration

(Case M.10555 – ADIA / TRANSURBAN / AUSTRALIANSUPER / CPP INVESTMENTS / WCX)

(Text with EEA relevance)

(2022/C 85/03)

On 8 February 2022, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10555. EUR-Lex is the online point of access to European Union law.

(1) OJ L 24, 29.1.2004, p. 1.
Non-opposition to a notified concentration

(Case M.10212 – ANDEL / ENERGI DANMARK)

(Text with EEA relevance)

(2022/C 76/02)

On 29 October 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10212. EUR-Lex is the online point of access to European Union law.

(1) OJ L 24, 29.1.2004, p. 1.
Non-opposition to a notified concentration

(Case M.10608 – CMA CGM / CLS BUSINESS)

(Text with EEA relevance)

(2022/C 102/02)

On 25 February 2022, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10608. EUR-Lex is the online point of access to European Union law.

(1) OJ L 24, 29.1.2004, p. 1.
Non-opposition to a notified concentration

(Case M.9969 – VEOLIA / SUEZ)

(Text with EEA relevance)

(2022/C 93/01)

On 14 December 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) in conjunction with Article 6(2) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in French language and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M9969. EUR-Lex is the online point of access to European Union law.

(1) OJ L 24, 29.1.2004, p. 1.
Non-opposition to a notified concentration

(Case M.10566 – P66 / H2 EE / JV)

(Text with EEA relevance)

(2022/C 118/03)

On 4 March 2022, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10566. EUR-Lex is the online point of access to European Union law.

(1) OJ L 24, 29.1.2004, p. 1.
Prior notification of a concentration

(Case M.10611 – GENERALI FRANCE / LA MÉDICALE)

Candidate case for simplified procedure

(Text with EEA relevance)

(2022/C 111/04)

1. On 28 February 2022, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Generali France S.A. (‘Generali France’), belonging to the Generali Group, ultimately controlled by Assicurazioni Generali S.p.A. (Italy), — La Médicale S.A. (‘La Medicale’, France), controlled by Crédit Agricole S.A. (‘Credit Agricole’, France). Generali France will acquire within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the whole of La Médicale and of a portfolio of death covers and irreversible loss of autonomy covers insured by Predica Prévoyance Dialogue du Crédit Agricole S.A., a subsidiary of Crédit Agricole S.A., and marketed by La Médicale (the ‘Insurance Portfolio’) (2). The concentration is accomplished by way of purchase of shares and purchase of assets.

2. The business activities of the undertakings concerned: — Generali France is part of the Generali Group, an international group of companies active in the insurance and financial sector across the world. Generali France provides and distributes both life and non-life insurance products, — La Médicale is a French specialist insurer for healthcare professionals active in France and Monaco. It provides non-life insurance products and focuses on medical liability insurance. La Médicale offers a number of additional products, such as personal injuries, motor vehicle, property, liability, and legal insurance. La Médicale currently markets the Insurance Portfolio and the Insurance Portfolio will also be part of the acquisition carried out by Generali France.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (3) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.10611 – GENERALI FRANCE / LA MÉDICALE Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) The acquisitions by Generali France of La Médicale and the Insurance Portfolio constitute a single concentration pursuant to Article 3 of the Merger Regulation.

(3) OJ C 366, 14.12.2013, p. 5.
Non-opposition to a notified concentration

(Case M.10499 – STATE STREET / BBH (INVESTOR))

(Text with EEA relevance)

(2022/C 130/01)

On 24 February 2022, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10499. EUR-Lex is the online point of access to European Union law.

(1) OJ L 24, 29.1.2004, p. 1.
Non-opposition to a notified concentration

(Case M.10600 – EDFI / MUBADALA / EMERGE JV)

(Text with EEA relevance)

(2022/C 123/03)

On 11 March 2022, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10600. EUR-Lex is the online point of access to European Union law.

(1) OJ L 24, 29.1.2004, p. 1.
Non-opposition to a notified concentration

(Case M.10613 – PORSCHE AUSTRIA / WOLFGANG DENZEL AUTO / SAUBERMACHER DIENSTLEISTUNG / JV)

(Text with EEA relevance)

(2022/C 145/01)

On 21 March 2022, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10613. EUR-Lex is the online point of access to European Union law.

(1) OJ L 24, 29.1.2004, p. 1.
Official Journal of the European Union

Prior notification of a concentration

(Case M.10378 – VUB / SLOVENSKA SPORITELNA / TATRA BANKA / 365.BANK / CSOB / JV)

(Text with EEA relevance)

(2022/C 134/08)

1. On 17 March 2022, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Všeobecná úverová banka, a.s. (‘VUB’, Slovakia), controlled by Intesa Sanpaolo S.p.A. (Italy), — Slovenská sporiteľňa, a.s. (‘Slovenska Sporitelna’, Slovakia), controlled by Erste Group Bank AG (Austria), — Tatra banka, a.s. (‘Tatra Banka’, Slovakia), controlled by Raiffeisen Bank International AG (Austria), — 365.bank, a.s. (‘365.bank’, Slovakia; before 3 July 2021 registered as Poštová banka, a.s.), controlled by J&T FINANCE GROUP SE (Czechia), — Československá obchodná banka, a.s. (‘CSOB’, Slovakia), controlled by KBC Group N.V. (Belgium). VUB, Slovenska Sporitelna, Tatra Banka, 365.bank and CSOB will acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of a newly created joint venture (the ‘JV’). The concentration is accomplished by way of purchase of shares in a newly created company constituting a joint venture.

2. The business activities of the undertakings concerned: — VUB, Slovenska Sporitelna, Tatra Banka, 365.bank and CSOB are commercial banks in Slovakia active in retail and corporate banking, — The JV will provide cash handling, cash in transit and cash management services.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.10378 – VUB / SLOVENSKA SPORITELNA / TATRA BANKA / 365.BANK / CSOB / JV Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).
Non-opposition to a notified concentration

(Case M.10632 – WATERLAND / DUVENBECK)

(Text with EEA relevance)

(2022/C 159/03)

On 25 March 2022, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10632. EUR-Lex is the online point of access to European Union law.

(1) OJ L 24, 29.1.2004, p. 1.
Non-opposition to a notified concentration

(Case M.10602 – SWISS LIFE INTERNATIONAL HOLDING / ELIPS LIFE)

(Text with EEA relevance)

(2022/C 154/01)

On 1 April 2022, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10602. EUR-Lex is the online point of access to European Union law.

(1) OJ L 24, 29.1.2004, p. 1.